Paper41816596
A nine-gene nicotine-metabolism signature predicts prognosis and characterizes the immune landscape in colon adenocarcinoma.
Li J and 6 others. J Gastrointest Oncol, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. A nine-gene nicotine-metabolism signature predicts prognosis and characterizes the immune landscape in colon adenocarcinoma. Papers, record 41816596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41816596
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A nine-gene nicotine-metabolism signature predicts prognosis and characterizes the immune landscape in colon adenocarcinoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36604116 | Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. | Gut | 2023 | https://conductscience.org/library/papers/36604116 | PubMed |
| 2 | 36755301 | Metabolic reprogramming in colorectal cancer: regulatory networks and therapy. | Cell Biosci | 2023 | https://conductscience.org/library/papers/36755301 | PubMed |
| 3 | 31443682 | Statistical predictions with glmnet. | Clin Epigenetics | 2019 | https://conductscience.org/library/papers/31443682 | PubMed |
| 4 | 36591255 | Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma. | Front Immunol | 2022 | https://conductscience.org/library/papers/36591255 | PubMed |
| 5 | 17907291 | Neural cell adhesion molecule-180 expression as a prognostic criterion in colorectal carcinoma: feasible or not? | World J Gastroenterol | 2007 | https://conductscience.org/library/papers/17907291 | PubMed |
| 6 | 21746875 | Stanniocalcin 2 is a negative modulator of store-operated calcium entry. | Mol Cell Biol | 2011 | https://conductscience.org/library/papers/21746875 | PubMed |
| 7 | 19114008 | WGCNA: an R package for weighted correlation network analysis. | BMC Bioinformatics | 2008 | https://conductscience.org/library/papers/19114008 | PubMed |
| 8 | 35070407 | Identification and validation of xenobiotic metabolism-associated prognostic signature based on five genes to evaluate immune microenvironment in colon cancer. | J Gastrointest Oncol | 2021 | https://conductscience.org/library/papers/35070407 | PubMed |
| 9 | 38369589 | TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association. | Sci Rep | 2024 | https://conductscience.org/library/papers/38369589 | PubMed |
| 10 | 29113264 | Cancer cell-expressed B7-H3 regulates the differentiation of tumor-associated macrophages in human colorectal carcinoma. | Oncol Lett | 2017 | https://conductscience.org/library/papers/29113264 | PubMed |
| 11 | 39678492 | Crosstalk between lactate and tumor-associated immune cells: clinical relevance and insight. | Front Oncol | 2024 | https://conductscience.org/library/papers/39678492 | PubMed |
| 12 | 39773485 | FOXC1-mediated serine metabolism reprogramming enhances colorectal cancer growth and 5-FU resistance under serine restriction. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/39773485 | PubMed |
| 13 | 24605266 | Targeting human CD27 with an agonist antibody stimulates T-cell activation and antitumor immunity. | Oncoimmunology | 2014 | https://conductscience.org/library/papers/24605266 | PubMed |
| 14 | 27007859 | Joint modeling of longitudinal and survival data with the Cox model and two-phase sampling. | Lifetime Data Anal | 2017 | https://conductscience.org/library/papers/27007859 | PubMed |
| 15 | 21210228 | Nicotine enhances colon cancer cell migration by induction of fibronectin. | Ann Surg Oncol | 2011 | https://conductscience.org/library/papers/21210228 | PubMed |
| 16 | 17498763 | Nicotine promotes cell proliferation via alpha7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes-mediated pathway in human colon adenocarcinoma HT-29 cells. | Toxicol Appl Pharmacol | 2007 | https://conductscience.org/library/papers/17498763 | PubMed |
| 17 | 29929486 | Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer. | BMC Cancer | 2018 | https://conductscience.org/library/papers/29929486 | PubMed |
| 18 | 32849517 | Myeloid-Derived Suppressor Cells in Colorectal Cancer. | Front Immunol | 2020 | https://conductscience.org/library/papers/32849517 | PubMed |
| 19 | 34557778 | clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. | Innovation (Camb) | 2021 | https://conductscience.org/library/papers/34557778 | PubMed |
| 20 | 36638198 | A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study. | Clin Cancer Res | 2023 | https://conductscience.org/library/papers/36638198 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42558886 | Integrated single-cell and spatial transcriptomic analyses identify TRIP6 as a prognostic and EMT-associated biomarker in colorectal cancer. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42558886 |
Source PubMed
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CST2 | 1470 | PubTator's text mining | https://conductscience.org/library/genes/1470 | NCBI Gene |
| FOXC1 | 2296 | PubTator's text mining | https://conductscience.org/library/genes/2296 | NCBI Gene |
| GPRASP1 | 9737 | PubTator's text mining | https://conductscience.org/library/genes/9737 | NCBI Gene |
| NRCAM | 4897 | PubTator's text mining | https://conductscience.org/library/genes/4897 | NCBI Gene |
| SIX2 | 10736 | PubTator's text mining | https://conductscience.org/library/genes/10736 | NCBI Gene |
| STC2 | 8614 | PubTator's text mining | https://conductscience.org/library/genes/8614 | NCBI Gene |
| TIMP1 | 7076 | PubTator's text mining | https://conductscience.org/library/genes/7076 | NCBI Gene |
| TRIP6 | 7205 | PubTator's text mining | https://conductscience.org/library/genes/7205 | NCBI Gene |
| TSPAN11 | 441631 | PubTator's text mining | https://conductscience.org/library/genes/441631 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41816596
GET https://conductscience.org/api/papers/v1/41816596/references?page=2